In the ARA + 4 Gy vs 4 Gy comparison, the PI3K–Akt signaling pathway and pathways in cancer were significantly stimulated by ARA treatment, suggesting that ARA might function as a radioprotectant in mice by promoting intestinal epithelial cell proliferation (Fig. 7D). The gene discussed is AKT1; the disease is cancer.